Year | 2011 | 2012 | ||||||
---|---|---|---|---|---|---|---|---|
Cluster groups | Best n = 0 | Average n = 2 | Poor n = 63 | Outlier n = 2 | Best n = 173 | Average n = 256 | Poor n = 328 | Outlier n = 34 |
MOH 731-5 post-exposure prophylaxis completeness | 0.00 | 54.20 | 13.48 | 95.85 | 84.98 | 54.24 | 23.56 | 89.71 |
MOH 731-5 post-exposure prophylaxis timeliness | 0.00 | 4.15 | 6.18 | 8.35 | 73.74 | 44.72 | 15.65 | 34.07 |
Year | 2013 | 2014 | ||||||
---|---|---|---|---|---|---|---|---|
Cluster groups | Best n = 583 | Average n = 281 | Poor n = 205 | Outlier n = 85 | Best n = 677 | Average n = 221 | Poor n = 124 | Outlier n = 281 |
MOH 731-5 post-exposure prophylaxis completeness | 94.44 | 61.18 | 29.01 | 87.45 | 97.04 | 56.66 | 23.39 | 83.53 |
MOH 731-5 post-exposure prophylaxis timeliness | 88.01 | 51.75 | 20.00 | 41.74 | 93.14 | 40.20 | 17.24 | 63.91 |
Year | 2015 | 2016 | ||||||
---|---|---|---|---|---|---|---|---|
Cluster groups | Best n = 954 | Average n = 305 | Poor n = 103 | Outlier n = 67 | Best n = 953 | Average n = 161 | Poor n = 61 | Outlier n = 387 |
MOH 731-5 post-exposure prophylaxis completeness | 97.14 | 76.33 | 27.25 | 78.37 | 98.15 | 59.58 | 27.85 | 83.22 |
MOH 731-5 post-exposure prophylaxis timeliness | 93.05 | 62.86 | 22.34 | 29.24 | 95.37 | 46.37 | 22.83 | 70.99 |
Year | 2017 | 2018 | ||||||
---|---|---|---|---|---|---|---|---|
Cluster groups | Best n = 1031 | Average n = 267 | Poor n = 137 | Outlier n = 127 | Best n = 725 | Average n = 407 | Poor n = 263 | Outlier n = 20 |
MOH 731-5 post-exposure prophylaxis completeness | 95.73 | 66.51 | 38.29 | 90.02 | 85.04 | 54.06 | 24.07 | 80.50 |
MOH 731-5 post-exposure prophylaxis timeliness | 91.35 | 59.21 | 28.23 | 54.50 | 82.38 | 49.99 | 20.32 | 36.46 |